If they sell the business, they can use that cash to buyout the shareholders or at least do a buyback.
So wouldn't you want to wait? You can get the time from your iPhone ;-)
Yes, I did. They were hot. Not getting that vibe with this one. In fact, my wife has an iPhone, my manager, coworker, and a bunch of friends, and none are interested in the watch. Too expensive, battery doesn't last, screen too tiny, and for many apps you still need to carry the phone. Why would you want to spend $300+ on something that does less than your phone and will be obsolete when the next one comes out. At least with the phone, you got it for $199 on contract. This one has no such deal.
I think Apple is a fine company. My brother bought an Apple II before they even had a floppy drive. We've been Apple fans for many years, but I don't think the watch is going to be the gangbuster must-have device everyone thinks.
I don't know a single person who has one nor do I know anyone interested in getting one. However, I do know people with Fitbit and Samsung gear.
injectable product is used when needed. Pill must be taken daily and for that reason probably more expensive in the long run.
They will get a NASDAQ compliance notice in a few weeks. They will have to do something to get the share price over $1. I imagine they will institute a buyback program. For this reason, I'm backing up the truck. Should be easy 20%.
$100M shelf in place already. Filing is what caused the dip. They will sell into strength today. Sell in pre-market before they unload these shares.
The company really needed a partner, if not to do the studies, then to market the product. Plus, everyone knows a pill or shot, in this case, does not do it for women.
Though I was long and already made my profit selling in post-market after news, I will go short today if I can around 1.50.
I believe they have a PR ready to piggyback on Sprout's drug approval. They will sell these shares into strength. That's why they filed today, to be in position to do this.
I wouldn't go so far as to say FitBit is calling on CNTF. It's rather the other way around. We need a direct connection from someone here who knows one of the executives.
I know of a Chinese firm that makes ruggedized sports watches that would like to get in touch.
Downside risk is in multiple contractions across the board. Netflix's P/E could drop from 260 down to 100 and even that would be high. I expect it trades at 103 in 2 weeks.
maybe they will buy AMZN and then the stock will soar. Just goes to show how relative valuations don't matter. Folks, this is a buying opportunity. Waiting for the low 60's, then back up the truck. You have to look for strong companies during a weak period. Look at what PCLN, AMZN, NFLX, AAPL after the economy tanked which survived and thrived. Looking for blood in the streets.
They will switch to Chinese. Actually, when the US went into recession, eBay took off as people started selling stuff on eBay to raise money or start a little side business to generate more income. I'm hoping the stock will crater to 60's. Then I'll back up the truck. They are diversifying into India and Latin America as well as the US, so the devaluation shouldn't hit them too hard.
Plus, don't forget the A-Watch. If they cut a deal with FitBit, $6 will look like a distant memory. You should see the video at media.corporate-ir.net\media_files\IROL\18\189668\all_models_x264a.mp4